Access Company Profile and SWOT Reports: Pharmaceuticals, Bio and more Reviewed at RnRCompanyProfiles.com
Access Company Profile and SWOT Reports: Pharmaceuticals, Bio and more Reviewed atRnRCompanyProfiles.comAccess Co., Ltd. (Access) is a mobile software development company. It is principally engaged indesigning, development and offering software technologies to mobile and non PC market segment. Itoffers a wide range of products, including Garnet operating system, ACCESS Linux platform, NetFrontmobile client suite, NetFront browser for mobile, networking solutions and server solutions and relatedservices. The company’s product portfolio encompasses a range of markets from mobilecommunications to non PC electronics market such as handhelds, internet terminals, cameras, copiers,home appliances, network equipments, IP phones, fax machines, video game consoles, set up boxes,automobile navigation, amongst others. Access operates through its offices across Asia, Europe andNorth America. The company is headquartered in Tokyo, Japan.This comprehensive SWOT profile of Access Co., Ltd. (http://www.rnrcompanyprofiles.com/access-co-ltd-4813-financial-and-strategic-swot-analysis-review-report.html) provides you an in-depth strategicanalysis of the company’s businesses and operations. The profile has been compiled by GlobalData tobring to you a clear and an unbiased view of the company’s key strengths and weaknesses and thepotential opportunities and threats. The profile helps you formulate strategies that augment yourbusiness by enabling you to understand your partners, customers and competitors better.Buy a copy of report @ http://www.rnrcompanyprofiles.com/contacts/purchase?rname=72699.Access Pharmaceuticals, Inc. (ACCP) – Financial and Strategic SWOT Analysis Review -http://www.rnrcompanyprofiles.com/access-pharmaceuticals-inc-accp-financial-and-strategic-swot-analysis-review-report.htmlAccess Pharmaceuticals, Inc., a biopharmaceutical company. It develops novel therapeutics for thetreatment of cancer and supportive care of cancer patients. The company’s products include MuGardfor the management of patients with mucositis; and ProLindac, a nanopolymer DACH-platinum prodrugthat is in Phase II clinical trial for the treatment of ovarian cancer. It also has other advanced drugdelivery technologies, such as CobaCyte-mediated targeted delivery technology and CobOral, apreclinical nanopolymer oral drug delivery technology based on the natural vitamin B12 oral uptakemechanism. The company has a collaborative agreement with RNAi industry to develop CobaCyte andCobOral technology for the delivery of RNAi therapeutics. Access Pharmaceuticals, Inc.is headquarteredin Dallas, Texas.Buy a copy of report @ http://www.rnrcompanyprofiles.com/contacts/purchase?rname=61955.Access Bio, Inc. – Strategic SWOT Analysis Review - http://www.rnrcompanyprofiles.com/access-bio-inc-strategic-swot-analysis-review-report.htmlAccess Bio, Inc. (Access Bio) is a privately held medical technology company. It undertakes thedevelopment, manufacture and marketing of In-Vitro diagnostics tests. The company’s advanced ROSGene POCT lateral flow technology is used for the production of its point-of-care diagnostics. The
company offers malaria and pregnancy detection kits. Its product pipeline includes cardiac markers,tumor markers and several other innovative rapid diagnostic products which soon to be launched intothe market. It has also developed novel technologies for processing reagents and has produced thesetests to meet the Food and Drug Association (FDA) standards. Access Bio is headquartered in NewJersey, the US.Buy a copy of report @ http://www.rnrcompanyprofiles.com/contacts/purchase?rname=72411.The profile contains critical company information:- Business description – A detailed description of the company’s operations and business divisions.- Corporate strategy – Analyst’s summarization of the company’s business strategy.- Access SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities andthreats.- Company history – Progression of key events associated with the company.- Major products and services – A list of major products, services and brands of the company.- Key competitors – A list of key competitors to the company.- Key employees – A list of the key executives of the company.- Executive biographies – A brief summary of the executives’ employment history.- Key operational heads – A list of personnel heading key departments/functions.- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of thecompany.- Detailed financial ratios for the past five years – The latest financial ratios derived from the annualfinancial statements published by the company with 5 years history.- Interim ratios for the last five interim periods – The latest financial ratios derived from thequarterly/semi-annual financial statements published by the company for 5 interims history.Key benefits of buying this profile include: You get detailed information about the company and its operations to identify potentialcustomers and suppliers. Understand and respond to your competitors’ business structure and strategies, and capitalizeon their weaknesses. Stay up to date on the major developments affecting the company. Equip yourself with information that enables you to sharpen your strategies and transform youroperations profitably. Scout for potential investments and acquisition targets, with detailed insight into thecompanies’ strategic, financial and operational performance. Gain key insights into the company for academic or business research.About:RnRCompanyProfiles.com is your single source for all competitive intelligence data, reports on companyprofiles and SWOT analysis of business organizations.